EcoDrugPlus

Aldose Reductase-Like

Ensembl ID : ENSPKIG00000009077
Gene Symbol: LOC111859027
3 Cross references
297 Possible Orthologues:

Alpha Glucosidase

Ensembl ID : ENSPKIG00000008286
Gene Symbol: GAA
3 Cross references
234 Possible Orthologues:

Alpha-1a Adrenergic Receptor-Like

Ensembl ID : ENSPKIG00000023915
Gene Symbol: LOC111839412
3 Cross references
200 Possible Orthologues:

Alpha-2b Adrenergic Receptor-Like

Ensembl ID : ENSPKIG00000001292
Gene Symbol: LOC111857482
3 Cross references
174 Possible Orthologues:

Amine Oxidase Copper Containing 1

Ensembl ID : ENSPKIG00000009531
Gene Symbol: AOC1
3 Cross references
231 Possible Orthologues:

Amine Oxidase Copper Containing 3

Ensembl ID : ENSPKIG00000001770
Gene Symbol: AOC3
3 Cross references
411 Possible Orthologues:

Amylase Alpha 1c

Ensembl ID : ENSPKIG00000001912
Gene Symbol: AMY1C
4 Cross references
213 Possible Orthologues:

Amyloid Beta Precursor Protein

Ensembl ID : ENSPKIG00000010598
Gene Symbol: APP
3 Cross references
275 Possible Orthologues:

Androgen Receptor

Ensembl ID : ENSPKIG00000012722
Gene Symbol: AR
3 Cross references
276 Possible Orthologues:

Androgen Receptor-Like

Ensembl ID : ENSPKIG00000019840
Gene Symbol: LOC111859806
2 Cross references
276 Possible Orthologues:

Angiotensin Ii Receptor Type 1

Ensembl ID : ENSPKIG00000021582
Gene Symbol: AGTR1
3 Cross references
207 Possible Orthologues:

Angiotensin Ii Receptor Type 2

Ensembl ID : ENSPKIG00000022154
Gene Symbol: AGTR2
3 Cross references
185 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).